Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001951427 | SCV002239674 | pathogenic | Ataxia-telangiectasia syndrome | 2021-08-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys2835Trpfs*13) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with ATM-related conditions. For these reasons, this variant has been classified as Pathogenic. |
Myriad Genetics, |
RCV004044398 | SCV004933703 | pathogenic | Familial cancer of breast | 2024-02-02 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |